Summary
The high incidence and mortality associated with Mycobacterium tuberculosis (M. tb) bring forward the necessity of rapid and accurate diagnosis. Microfluidic techniques present characteristics able to cover the gaps between current assays and clinical needs for disease management. Moreover, they bring a cost- and time-effective Point of Care (PoC) diagnosis methodology, with multiples advantages of special importance in countries with low income and resources. The devices can be classified according to the diagnosis method, which can be based on the detection of bacterial elements (such as enzymes or antibodies) or on genotyping through amplification of the nucleic acid information. In the latter case, there are devices capable of providing information about the drug resistance of the particular strains, while others provide just a “yes/no” answer, differentiating M. tb from other mycobacterial infections. The main goal attempted by all the devices remains to achieve portability and ease of use required for a PoC device, besides the required precision.
Graphical Abstract
As any doctor can tell you, the most crucial step toward healing is having the right diagnosis. If the disease is precisely identified, a good resolution is far more likely. Conversely, a bad diagnosis usually means a bad outcome, no matter how skilled the physician.
Andrew Weil
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Notes
- 1.
Dual-targeting fluorogenic probe with a BlaC sensing unit, a fluorescent reporter and an enzymatic signal trapping unit.
- 2.
FlowJo v10.
References
World Health Organization (2019) Global tuberculosis report 2019
Jilani TN, Avula A, Zafar Gondal A, Siddiqui AH (2020) Active tuberculosis. In: StatPearls. StatPearls Publishing, Treasure Island (FL)
Davies PDO, Pai M (2008) The diagnosis and misdiagnosis of tuberculosis. Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis 12:1226–1234
Mani V, Wang S, Inci F, De Libero G, Singhal A, Demirci U (2014) Emerging technologies for monitoring drug-resistant tuberculosis at the point-of-care. Adv Drug Deliv Rev 78:105–117. https://doi.org/10.1016/j.addr.2014.05.015
Wang S, Inci F, De Libero G, Singhal A, Demirci U (2013) Point-of-care assays for tuberculosis: role of nanotechnology/microfluidics. Biotechnol Adv 31:438–449. https://doi.org/10.1016/j.biotechadv.2013.01.006
Dheda K, Ruhwald M, Theron G, Peter J, Yam WC (2013) Point-of-care diagnosis of tuberculosis: past, present and future. Respirol Carlton Vic 18:217–232. https://doi.org/10.1111/resp.12022
Ventola CL (2015) The antibiotic resistance crisis: part 1: causes and threats. P T Peer-Rev J Formul Manag 40:277–283
Eker B, Ortmann J, Migliori GB, Sotgiu G, Muetterlein R, Centis R, Hoffman H, Kirsten D, Schaberg T, Ruesch-Gerdes S, Lange C (2008) Multidrug- and extensively drug-resistant tuberculosis, Germany. Emerg Infect Dis 14:1700–1706. https://doi.org/10.3201/eid1411.080729
Young DB, Perkins MD, Duncan K, Barry CE 3rd (2008) Confronting the scientific obstacles to global control of tuberculosis. J Clin Invest 118:1255–1265. https://doi.org/10.1172/JCI34614
Blöndal K (2007) Barriers to reaching the targets for tuberculosis control: multidrug-resistant tuberculosis. Bull World Health Organ 85:387–90; discussion 391–394. https://doi.org/10.2471/06.035345
Yang TW, Park HO, Jang HN, Yang JH, Kim SH, Moon SH, Buyn JH, Lee CE, Kim JW, Kang DH (2017) Side effects associated with the treatment of multidrug-resistant tuberculosis at a tuberculosis referral hospital in South Korea: a retrospective study. Medicine (Baltimore) 96:e7482. https://doi.org/10.1097/MD.0000000000007482
Ahn CH, Choi J-W (2010) Microfluidic devices and their applications to lab-on-a-chip. In: Bhushan B (ed) Springer handbook of nanotechnology. Springer, Berlin, Heidelberg, pp 503–530
Polla DL, Erdman AG, Robbins WP, Markus DT, Diaz-Diaz J, Rizq R, Nam Y, Brickner HT, Wang A, Krulevitch P (2000) Microdevices in medicine. Annu Rev Biomed Eng 2:551–576. https://doi.org/10.1146/annurev.bioeng.2.1.551
Hauck TS, Giri S, Gao Y, Chan WCW (2010) Nanotechnology diagnostics for infectious diseases prevalent in developing countries. Adv Drug Deliv Rev 62:438–448. https://doi.org/10.1016/j.addr.2009.11.015
Albert-Smet I, Marcos-Vidal A, Vaquero JJ, Desco M, Muñoz-Barrutia A, Ripoll J (2019) Applications of light-sheet microscopy in microdevices. Front Neuroanat 13:1. https://doi.org/10.3389/fnana.2019.00001
Xie H, Mire J, Kong Y, Chang M, Hassounah HA, Thornton CN, Sacchettini JC, Cirillo JD, Rao J (2012) Rapid point-of-care detection of the tuberculosis pathogen using a BlaC-specific fluorogenic probe. Nat Chem 4:802–809. https://doi.org/10.1038/nchem.1435
Sule P, Tilvawala R, Mustapha T, Hassounah H, Noormohamed A, Kundu S,Graviss EA, Walkup GK, Kong Y, Cirillo JD (2019) Rapid tuberculosis diagnosis using reporter enzyme fluorescence. J Clin Microbiol 57. https://doi.org/10.1128/JCM.01462-19
Lyu F, Xu M, Cheng Y, Xie J, Rao J, Tang SK (2015) Quantitative detection of cells expressing BlaC using droplet-based microfluidics for use in the diagnosis of tuberculosis. Biomicrofluidics 9:044120. https://doi.org/10.1063/1.4928879
Cheng Y, Xie J, Lee K-H, Gaur RL, Song A, Dai T, Ren H, Wu J, Sun Z, Banaei N, Akin D, Rao J (2018) Rapid and specific labeling of single live Mycobacterium tuberculosis with a dual-targeting fluorogenic probe. Sci Transl Med 10. https://doi.org/10.1126/scitranslmed.aar4470
Darwish IA (2006) Immunoassay methods and their applications in pharmaceutical analysis: basic methodology and recent advances. Int J Biomed Sci IJBS 2:217–235
Jing W, Jiang X, Zhao W, Liu S, Cheng X, Sui G (2014) Microfluidic platform for direct capture and analysis of airborne Mycobacterium tuberculosis. Anal Chem 86:5815–5821. https://doi.org/10.1021/ac500578h
Whitelaw A, Sturm W (2009) Microbiological testing for Mycobacterium tuberculosis. Tuberc Compr Clin Ref 1st Ed 169–178
Chan ED, Reves R, Belisle JT, Brennan PJ, Hahn WE (2000) Diagnosis of tuberculosis by a visually detectable immunoassay for lipoarabinomannan. Am J Respir Crit Care Med 161:1713–1719. https://doi.org/10.1164/ajrccm.161.5.9908125
Songkhla MN, Tantipong H, Tongsai H, Angkasekwinai N (2019) Lateral flow urine lipoarabinomannan assay for diagnosis of active tuberculosis in adults with human immunodeficiency virus infection: a prospective cohort study. Open Forum Infect Dis 6:ofz132. https://doi.org/10.1093/ofid/ofz132
Sigal GB, Pinter A, Lowary TL, Kawasaki M, Li A, Mathew A, Tsionsky RB, Plisova T, Shen K, Katsuragi K, Choudhary A, Honnen WJ, Nahid P, Denkinger CM, Broger T (2018) A novel sensitive immunoassay targeting the 5-methylthio-d-xylofuranose-lipoarabinomannan epitope meets the WHO’s performance target for tuberculosis diagnosis. J Clin Microbiol 56. https://doi.org/10.1128/JCM.01338-18
Ramirez-Priego P, Martens D, Elamin AA, Soetaert P, Van Roy W, Vos R, Anton B, Bockstaele R, Becker H, Singh M, Bienstman P, Lechuga LM (2018) Label-free and real-time detection of tuberculosis in human urine samples using a nanophotonic point-of-care platform. ACS Sens 3:2079–2086. https://doi.org/10.1021/acssensors.8b00393
Peralta G, Barry P, Pascopella L (2016) Use of nucleic acid amplification tests in tuberculosis patients in California, 2010–2013. Open Forum Infect Dis 3:ofw230. https://doi.org/10.1093/ofid/ofw230
Eddabra R, Ait Benhassou H (2018) Rapid molecular assays for detection of tuberculosis. Pneumonia Nathan Qld 10:4. https://doi.org/10.1186/s41479-018-0049-2
Massung RF (2005) DNA amplification: current technologies and applications. Emerg Infect Dis 11:357–357. https://doi.org/10.3201/eid1102.041049
Zeka AN, Tasbakan S, Cavusoglu C (2011) Evaluation of the GeneXpert MTB/RIF assay for rapid diagnosis of tuberculosis and detection of rifampin resistance in pulmonary and extrapulmonary specimens. J Clin Microbiol 49:4138–4141. https://doi.org/10.1128/JCM.05434-11
Saeed M, Ahmad M, Iram S, Riaz S, Akhtar M, Aslam M (2017) GeneXpert technology. A breakthrough for the diagnosis of tuberculous pericarditis and pleuritis in less than 2 hours. Saudi Med J 38:699–705. https://doi.org/10.15537/smj.2017.7.17694
Mangayarkarasi V, Sneka P, Sujith R, Jayaprakash J (2019) Ergonomic diagnostic tool based on chip mini RT-PCR for diagnosis of pulmonary and extra pulmonary tuberculosis. J Pure Appl Microbiol 13:1185–1190. https://doi.org/10.22207/JPAM.13.2.58
Nikam C, Kazi M, Nair C, Jaggannath M, Manoj M, Vinaya R, Shetty A, Rodrigues C (2014) Evaluation of the Indian TrueNAT micro RT-PCR device with GeneXpert for case detection of pulmonary tuberculosis. Int J Mycobacteriology 3:205–210. https://doi.org/10.1016/j.ijmyco.2014.04.003
Rafati A, Gill P (2014) Microfluidic method for rapid turbidimetric detection of the DNA of Mycobacterium tuberculosis using loop-mediated isothermal amplification in capillary tubes. Microchim Acta 182:523–530. https://doi.org/10.1007/s00604-014-1354-y
Luo J, Fang X, Ye D, Li H, Chen H, Zhang S, Kong J (2014) A real-time microfluidic multiplex electrochemical loop-mediated isothermal amplification chip for differentiating bacteria. Biosens Bioelectron 60C:84–91. https://doi.org/10.1016/j.bios.2014.03.073
Yang H, Chen Z, Cao X, Li Z, Stavrakis S, Choo J, DeMello AJ, Howes PD, He N (2018) A sample-in-digital-answer-out system for rapid detection and quantitation of infectious pathogens in bodily fluids. Anal Bioanal Chem 410. https://doi.org/10.1007/s00216-018-1335-9
Versiani A, Andrade L, Martins E, Scalzo S, Geraldo JM, Chaves CR, Ferreira DC, Ladeira M, Guatimosim S, Ladeira L, da Fonseca FG (2016) Gold nanoparticles and their applications in biomedicine. Future Virol 13. https://doi.org/10.2217/fvl-2015-0010
Costa P, Amaro A, Botelho A, Inácio J, Baptista PV (2010) Gold nanoprobe assay for the identification of mycobacteria of the Mycobacterium tuberculosis complex. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 16:1464–1469. https://doi.org/10.1111/j.1469-0691.2009.03120.x
Bernacka-Wojcik I, Lopes P, Vaz AC, Veigas B, Wojcik PJ, Simões P, Barata D, Fortunato E, Baptista PV, Aguas H, Martins R (2013) Bio-microfluidic platform for gold nanoprobe based DNA detection–application to Mycobacterium tuberculosis. Biosens Bioelectron 48:87–93. https://doi.org/10.1016/j.bios.2013.03.079
Costa MN, Veigas B, Jacob JM, Santos DS, Gomes J, Baptista JV, Martins R, Inácio J, Fortunato E (2014) A low cost, safe, disposable, rapid and self-sustainable paper-based platform for diagnostic testing: lab-on-paper. Nanotechnology 25:094006. https://doi.org/10.1088/0957-4484/25/9/094006
Baptista P, Pereira E, Eaton P, Doria G, Miranda A, Gomes I, Quaresma P, Franco R (2008) Gold nanoparticles for the development of clinical diagnosis methods. Anal Bioanal Chem 391:943–950. https://doi.org/10.1007/s00216-007-1768-z
Tsai T-T, Huang C-Y, Chen C-A, Shen SW, Wang MC, Cheng CM, Chen CF (2017) Diagnosis of tuberculosis using colorimetric gold nanoparticles on a paper-based analytical device. ACS Sens 2:1345–1354. https://doi.org/10.1021/acssensors.7b00450
Nguyen HH, Park J, Kang S, Kim M (2015) Surface plasmon resonance: a versatile technique for biosensor applications. Sensors 15:10481–10510. https://doi.org/10.3390/s150510481
Bhusal N, Shrestha S, Pote N, Alocilja EC (2018) Nanoparticle-based biosensing of tuberculosis, an affordable and practical alternative to current methods. Biosensors 9. https://doi.org/10.3390/bios9010001
Gupta AK, Singh A, Singh S (2019) Diagnosis of tuberculosis: nanodiagnostics approaches. NanoBioMed 261–283. https://doi.org/10.1007/978-981-32-9898-9_11
Zribi B, Roy E, Pallandre A, Chebil S, Koubaa M, Mejri N, Gomez HM, Sola C, Horri-Youssoufi H, Haghiri-Gosnet AM (2016) A microfluidic electrochemical biosensor based on multiwall carbon nanotube/ferrocene for genomic DNA detection of Mycobacterium tuberculosis in clinical isolates. Biomicrofluidics 10:014115. https://doi.org/10.1063/1.4940887
Cohen KA, Manson AL, Desjardins CA, Abeel T, Earl AM (2019) Deciphering drug resistance in Mycobacterium tuberculosis using whole-genome sequencing: progress, promise, and challenges. Genome Med 11:45. https://doi.org/10.1186/s13073-019-0660-8
Linger Y, Knickerbocker C, Sipes D, Golova J, Franke M, Calderon R, Lecca L, Thakore HR, Qu P, Kukhtin A, Murray MB, Cooney C, Chandler D (2018) Genotyping multidrug-resistant Mycobacterium tuberculosis from primary sputum and decontaminated sediment with an integrated microfluidic amplification microarray test. J Clin Microbiol 56:e01652-17. https://doi.org/10.1128/JCM.01652-17
Pholwat S, Liu J, Stroup S, Gratz J, Banu S, Mazidur Rahman SM, Ferdous SS, Foongladda S, Boonlert D, Ogarkov O, Zhdanova S, Kibiki G, Heysell S, Houpt E (2015) Integrated microfluidic card with TaqMan probes and high-resolution melt analysis to detect tuberculosis drug resistance mutations across 10 genes. mBio 6:e02273. https://doi.org/10.1128/mBio.02273-14
Kim T-H, Sunkara V, Park J, Kim CJ, Woo HK, Cho YK (2016) A lab-on-a-disc with reversible and thermally stable diaphragm valves. Lab Chip 16:3741–3749. https://doi.org/10.1039/C6LC00629A
Law ILG, Loo JFC, Kwok HC, Yeung HY, Leung CHH, Hui M, Wu SY, Chan SH, Kwan YW, HoHP KSK (2018) Automated real-time detection of drug-resistant Mycobacterium tuberculosis on a lab-on-a-disc by recombinase polymerase amplification. Anal Biochem 544:98–107. https://doi.org/10.1016/j.ab.2017.12.031
Minero A, Bagnasco M, Fock J, Tian B, Garbarino B, Hansen MF (2020) Automated on-chip analysis of tuberculosis drug-resistance mutation with integrated DNA ligation and amplification. Anal Bioanal Chem 412:2705–2710. https://doi.org/10.1007/s00216-020-02568-x
Sher M, Zhuang R, Demirci U, Asghar W (2017) Paper-based analytical devices for clinical diagnosis: recent advances in the fabrication techniques and sensing mechanisms. Expert Rev Mol Diagn 17:351–366. https://doi.org/10.1080/14737159.2017.1285228
Kukhtin AC, Sebastian T, Golova J, Perov A, Knickerbocker C, Linger Y, Bueno A, Qu P, Villanueva M, Holmberg RC, Chandler DP, Cooney CG (2019) Lab-on-a-film disposable for genotyping multidrug-resistant Mycobacterium tuberculosis from sputum extracts. Lab Chip 19:1217–1225. https://doi.org/10.1039/C8LC01404C
Kukhtin AV, Norville R, Bueno A, Qu P, Parrish N, Murray M, Chandler DP, Holmberg RC, Cooney CG (2020) A benchtop automated sputum-to-genotype system using a lab-on-a-film assembly for detection of multidrug-resistant Mycobacterium tuberculosis. Anal Chem 92:5311–5318. https://doi.org/10.1021/acs.analchem.9b05853
Acknowledgements
This research has received funding from the project ERA4TB, Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 853989. The JU receives support from the European Union’s Horizon 2020 research and innovation program and EFPIA and Global Alliance for TB Drug Development nonprofit organization, Bill & Melinda Gates Foundation, and the University of Dundee. This work is supported in part by Ministerio de Ciencia, Innovación y Universidades, Agencia Estatal de Investigación, under grant PID2019-109820RB-I00, MCIN/AEI /https://doi.org/10.13039/501100011033/, cofinanced by European Regional Development Fund (ERDF), “A way of making Europe.”
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Cañadas-Ortega, M., Gómez-Cruz, C., Vaquero, J.J., Muñoz-Barrutia, A. (2023). The Role of Diagnostic Microdevices in the Fight Against Tuberculosis. In: Rezaei, N. (eds) Tuberculosis. Integrated Science, vol 11. Springer, Cham. https://doi.org/10.1007/978-3-031-15955-8_7
Download citation
DOI: https://doi.org/10.1007/978-3-031-15955-8_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-15954-1
Online ISBN: 978-3-031-15955-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)